Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia

ClinicalTrials.gov ID: NCT00003688

Public ClinicalTrials.gov record NCT00003688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pulse Actinomycin-D as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Neoplasia

Study identification

NCT ID
NCT00003688
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • dactinomycin Biological

Biological

Eligibility (public fields only)

Age range
12 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 1999
Primary completion
Aug 31, 2006
Completion
Not listed
Last update posted
Jun 9, 2013

Started 1999

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Community Hospital of Los Gatos Los Gatos California 95032
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868
MBCCOP - Hawaii Honolulu Hawaii 96813
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1009
Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky 40536-0084
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda Maryland 20892-1182
Tufts - New England Medical Center Boston Massachusetts 02111
University of Minnesota Cancer Center Minneapolis Minnesota 55455
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Cooper University Hospital Camden New Jersey 08103-1489
State University of New York Health Science Center at Brooklyn Brooklyn New York 11203
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11794-8091
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0526
Ireland Cancer Center Cleveland Ohio 44106
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190
Abington Memorial Hospital Abington Pennsylvania 19001-3788
Abramson Cancer Center at University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104-4283
Brookview Research, Inc. Nashville Tennessee 37203
University of Texas Medical Branch Galveston Texas 77555-0587
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-3236
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003688 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →